371 related articles for article (PubMed ID: 6314582)
1. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
Lechner K; Niessner H; Bettelheim P; Deutsch E; Fasching I; Fuhrmann M; Hinterberger W; Korninger C; Neumann E; Liszka K
Thromb Haemost; 1983 Aug; 50(2):552-6. PubMed ID: 6314582
[TBL] [Abstract][Full Text] [Related]
2. [Hemophilia and HTLV-III infection].
Lechler E
Z Hautkr; 1986 Dec; 61(23):1687-704. PubMed ID: 2949442
[TBL] [Abstract][Full Text] [Related]
3. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
Zenz W; Muntean W; Teubl I; Beaufort F; Heinz FX
Padiatr Padol; 1987; 22(1):33-41. PubMed ID: 3108827
[TBL] [Abstract][Full Text] [Related]
4. HTLV III antibodies and immunological alterations in hemophilia patients.
Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H
Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759
[TBL] [Abstract][Full Text] [Related]
5. Sequential clinical and immunologic abnormalities in hemophiliacs.
Goldsmith JM; Kalish SB; Green D; Chmiel JS; Wallemark CB; Phair JP
Arch Intern Med; 1985 Mar; 145(3):431-4. PubMed ID: 3919666
[TBL] [Abstract][Full Text] [Related]
6. Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate.
Tsoukas C; Gervais F; Fuks A; Guttmann RD; Strawczynski H; Shuster J; Gold P
Can Med Assoc J; 1983 Oct; 129(7):713-7. PubMed ID: 6225504
[TBL] [Abstract][Full Text] [Related]
7. [Immunological status of hemophiliacs: study of blood T-lymphocyte populations, serum immunoglobulins, and the prevalence of anti-LAV antibodies].
Aymard JP; Janot C; Briquel ME; André E; Schooneman F; Vigneron C; Legras B; Alexandre P; Streiff F
Pathol Biol (Paris); 1985 Dec; 33(10):951-6. PubMed ID: 3005949
[TBL] [Abstract][Full Text] [Related]
8. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
[TBL] [Abstract][Full Text] [Related]
9. Immunologic studies in asymptomatic hemophiliac patients.
Frydecka I; Kowalewska B; Lesiecki A; Kuliczkowski K; Palakowska A; Polkowski A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):708-15. PubMed ID: 2435638
[TBL] [Abstract][Full Text] [Related]
10. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
Abe T
AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population.
Carr R; Veitch SE; Edmond E; Peutherer JF; Prescott RJ; Steel CM; Ludlam CA
Lancet; 1984 Jun; 1(8392):1431-4. PubMed ID: 6145879
[TBL] [Abstract][Full Text] [Related]
12. HIV antibody status and immunological abnormalities in Polish haemophiliacs.
Lopaciuk S; Kacperska E; Gloskowska-Moraczewska Z; Maslanka K; Uhrynowska M; Kraj M; Seyfried H
Thromb Haemost; 1987 Feb; 57(1):41-3. PubMed ID: 3495899
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
Smolen JS; Bettelheim P; Köller U; McDougal S; Graninger W; Luger TA; Knapp W; Lechner K
J Clin Invest; 1985 Jun; 75(6):1828-34. PubMed ID: 2989334
[TBL] [Abstract][Full Text] [Related]
14. HTLV-III status and abnormalities in T lymphocyte distribution in children with hemophilia A.
Shannon BT; Roach J; Cheek-Luten M; Ruymann FB
Diagn Immunol; 1986; 4(1):37-42. PubMed ID: 3006971
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
Verani P; Mariani G; Mannucci PM; De Rossi G; Nicoletti L; Titti F; Falcione E; Pasqualetti D; Ammassari M; Gringeri A
J Med Virol; 1986 Jun; 19(2):143-9. PubMed ID: 3014059
[TBL] [Abstract][Full Text] [Related]
16. The course of preexistent immune abnormalities in HIV negative haemophiliacs treated for two years with a monoclonal purified factor VIII concentrate.
Smid WM; van der Meer J; Smit JW; Halie MR
Thromb Haemost; 1993 Apr; 69(4):306-10. PubMed ID: 8388579
[TBL] [Abstract][Full Text] [Related]
17. Lymphadenopathy-associated virus antibodies and T cells in hemophiliacs treated with cryoprecipitate or concentrate.
Gjerset GF; McGrady G; Counts RB; Martin PJ; Jason J; Kennedy S; Evatt B; Hansen JA
Blood; 1985 Sep; 66(3):718-20. PubMed ID: 2992642
[TBL] [Abstract][Full Text] [Related]
18. Immunological alterations in haemophiliacs treated with lyophilized Factor VIII cryoprecipitate from volunteer donors.
Ceuppens JL; Vermylen J; Colaert J; Desmyter J; Gautama K; Stevens E; The AL; Vanham G; Vermylen C; Verstraete M
Thromb Haemost; 1984 Apr; 51(2):207-11. PubMed ID: 6429883
[TBL] [Abstract][Full Text] [Related]
19. Abnormal T-cell subsets and mitogen responses in hemophiliacs exposed to factor concentrate.
Unzeitig JC; Church JA; Gomperts ED; Nye CA; Pasquale S; Richards W
Am J Dis Child; 1984 Jul; 138(7):645-8. PubMed ID: 6233901
[TBL] [Abstract][Full Text] [Related]
20. Impaired distribution of T-lymphocyte subsets in patients with haemophilia.
Lauria F; Guerrini L; Magni E; Mancino A; Monti G; Raspadori D
Boll Ist Sieroter Milan; 1984 May; 63(2):145-9. PubMed ID: 6331833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
